Development of a Patient Preference Survey for Wearable Kidney Replacement Therapy Devices.

التفاصيل البيبلوغرافية
العنوان:	Development of a Patient Preference Survey for Wearable Kidney Replacement Therapy Devices.
المؤلفون:	Flythe JE; University of North Carolina (UNC) Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.; Cecil G. Sheps Center for Health Services Research, UNC, Chapel Hill, North Carolina., Forfang D; Kidney Health Initiative Patient and Family Partnership Council, San Pablo, California., Gedney N; Home Dialyzors United, Shepherdstown, West Virginia., White DM; Kidney Health Initiative Patient and Family Partnership Council, Hillcrest Heights, Maryland., Wilkie C; Kidney Health Initiative Patient and Family Partnership Council, Punta Gorda, Florida., Cavanaugh KL; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee.; Center for Effective Health Communication, Vanderbilt University Medical Center, Nashville, Tennessee., Harris RC; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee., Unruh M; School of Medicine, University of New Mexico, Albuquerque, New Mexico., Squillaci G; Kidney Health Initiative and American Society of Nephrology, Washington, DC., West M; Kidney Health Initiative and American Society of Nephrology, Washington, DC., Mansfield C; RTI Health Solutions, Research Triangle Park, North Carolina., Soloe CS; RTI Health Solutions, Research Triangle Park, North Carolina., Treiman K; RTI International, Research Triangle Park, North Carolina., Wood D; RTI Health Solutions, Research Triangle Park, North Carolina., Hurst FP; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland., Neuland CY; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland., Saha A; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland., Sheldon M; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland., Tarver ME; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland.
المصدر:	Kidney360 [Kidney360] 2022 May 05; Vol. 3 (7), pp. 1197-1209. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).
نوع المنشور:	Journal Article; Research Support, N.I.H., Extramural
اللغة:	English
بيانات الدورية:	Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: eCollection Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE
أسماء مطبوعة:	Publication: 2023- : [Hagerstown, MD] : Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Original Publication: [Washington, DC] : American Society of Nephrology, [2020]-
مواضيع طبية MeSH:	Kidney Failure, Chronic/therapy , Wearable Electronic Devices, Humans ; Patient Preference ; Renal Dialysis ; Renal Replacement Therapy ; Surveys and Questionnaires
مستخلص:	Background: Recent innovations have the potential to disrupt the current paradigm for kidney failure treatment. The US Food and Drug Administration is committed to incorporating valid scientific evidence about how patients weigh the benefits and risks of new devices into their decision making, but to date, premarket submission of patient preference information (PPI) has been limited for kidney devices. With input from stakeholders, we developed a survey intended to yield valid PPI, capturing how patients trade off the potential benefits and risks of wearable dialysis devices and in-center hemodialysis. Methods: We conducted concept elicitation interviews with individuals receiving dialysis to inform instrument content. After instrument drafting, we conducted two rounds of pretest interviews to evaluate survey face validity, comprehensibility, and perceived relevance. We pilot tested the survey with in-center hemodialysis patients to assess comprehensibility and usability further. Throughout, we used participant input to guide survey refinements. Results: Thirty-six individuals receiving in-center or home dialysis participated in concept elicitation ( N =20) and pretest ( N =16) interviews. Participants identified reduced fatigue, lower treatment burden, and enhanced freedom as important benefits of a wearable device, and many expressed concerns about risks related to device disconnection-specifically bleeding and infection. We drafted a survey that included descriptions of the risks of serious bleeding and serious infection and an assessment of respondent willingness to wait for a safer device. Input from pretest interviewees led to various instrument modifications, including treatment descriptions, item wording, and risk-level explanations. Pilot testing of the updated survey among 24 in-center hemodialysis patients demonstrated acceptable survey comprehensibility and usability, although 50% of patients required some assistance. Conclusions: The final survey is a 54-item web-based instrument that will yield estimates of the maximal acceptable risk for the described wearable device and willingness to wait for wearable devices with lower risk. Competing Interests: K.L. Cavanaugh reports consultancy for the Kidney Health Initiative, REATA Pharmaceuticals, and Responsum Health; ownership interest in HCA Healthcare; and an advisory or leadership role for the National Kidney Foundation (KDQOI education committee), Clinical Journal of American Society of Nephrology (editorial board), American Journal of Kidney Diseases (editorial board), Kidney360 (associate editor), and Medical Decision Making (editorial board). J.E. Flythe reports consultancy for AstraZeneca and Fresenius Medical Care Medical Advisory Board; research funding from National Institutes of Health/National Heart, Lung, and Blood Institute, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, Patient-Centered Outcomes Research Institute, Renal Research Institute (subsidiary of Fresenius Medical Care, North America), and Robert Wood Johnson Foundation; honoraria from the American Society of Nephrology, National Kidney Foundation, and numerous universities; and an advisory or leadership role for the American Journal of Kidney Diseases (editorial board 2017–2021), Clinical Journal of American Society of Nephrology (editorial board 2017–), Hemodialysis (theme editor 2018–), KDIGO Executive Committee (2020–), Kidney Health Initiative (board of directors 2019–), Kidney Health Initiative (Patient Preferences Project chairperson 2019–), Kidney Medicine (editorial board 2019–), Kidney360 (associate editor 2019–), and Nephrology Dialysis and Transplantation (editorial board). D. Forfang reports employment by the American Society of Nephrology Kidney Health Initiative; consultancy for Ardelyx, Inc., Scientific Advisory Board, the American Society of Nephrology and Responsum, CareDX, HSAG, and University of North Carolina Kidney Center; honoraria from the American Society of Nephrology, European Association for Dialysis, HSAG ESRD Network #17, National Kidney Foundation; an advisory or leadership role for Arbor Research, HSAG ESRD Network #17 (board member), Kidney Health Initiative (Patient Advisory Committee), National Forum of ESRD Networks (board member), National Forum of ESRD Networks Kidney Patient Advisory Council (chair); National Kidney Foundation, SONG Group, and Unity Health Toronto OPPUS, UCSF Kidney Project (patient advisor); and other interests or relationships as a volunteer for the Forum of ESRD Networks as Kidney Patient Advisory Council chair and board member, a volunteer for ESRD Network #17 as Patient Advisory Committee Chair and Network board member, a volunteer for the National Kidney Foundation as a member of their Public Policy Committee, and a volunteer for the National Kidney Foundation as a Regional Leader of their Kidney Advocacy Committee, Kidney Health Initiative PFPC member. N. Gedney reports honoraria from the American Society of Nephrology, IDEAs, and the University of Washington. R.C. Harris reports consultancy for Bayer, Fibrocor, and Nicoya; ownership interest in Apple; research funding from Bayer; patents or royalties from eNOS db/db mouse; an advisory or leadership role for the Kidney Health Initiative (paid); and other interests or relationships with the Kidney Health Initiative (co-chair, board of directors). F.P. Hurst reports employment by the Food and Drug Administration/Center for Drug Evaluation and Research, and other interests or relationships with a US government employee. C. Mansfield reports the employment by RTI Health Solutions, which receives funding from for-profit pharmaceutical companies to conduct research. C.Y. Neuland reports being a member of the board of directors for the Kidney Health Initiative, representing the Food and Drug Administration/Center for Devices and Radiological Health during this time period. A. Saha reports employment by the Food and Drug Administration. C.S. Soloe reports employment by RTI International. G. Squillaci reports consultancy for The Griff Group. M.E. Tarver reports employment by the Food and Drug Administration/Center for Devices and Radiological Health. K. Treiman reports employment by RTI International. M.L. Unruh reports consultancy for Cara Therapeutics to chair of Data Monitoring Committee; a consulting agreement between Cara and the University of New Mexico; research funding from DCI; and honoraria related to lectures from the American Society of Nephrology, National Kidney Foundation, and Renal Research Institute. M. West reports employment by the American Society of Nephrology. D.M. White reports employment by Debevoise & Plimpton; consultancy for the Kidney Transplant Collaborative, the National Committee for Quality Assurance, and Responsum Health; ownership interest in Amgen, Inc.; honoraria from AstraZeneca, Hennepin Healthcare, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institutes of Health, New York Academy of Medicine, and PFCC partners; and other interests or relationships with the American Association of Kidney Patients, American Society of Transplantation, Kidney Health Initiative, National Kidney Foundation, National Patient Advocate Foundation, Patient Advocate Foundation, and Quality Insights. C. Wilkie reports employment by Kuhns Law Firm, PLLC; consultancy for the University of North Carolina, University of Pennsylvania, and University of Pittsburg; ownership interest in Kuhns Law Firm, PLLC; an advisory or leadership role for the Kidney Health Initiative, University of Pennsylvania with the HOPE Consortium, and University of Pittsburgh; and other interests or relationships with the Kidney Health Initiative, National Kidney Foundation, University of Pennsylvania with the HOPE Consortium, University of North Carolina at Chapel Hill, and University of Pittsburgh. D. Wood reports employment by RTI International. The remaining authors have nothing to disclose. (Copyright © 2022 by the American Society of Nephrology.)
References:	United States Renal Data System. 2021 USRDS annual data report: Epidemiology of kidney disease in the United States. Available at https://adr.usrds.org/2021. Accessed May 25, 2022. The White House: Executive Order on Advancing American Kidney Health. Available at: https://www.asn-online.org/policy/webdocs/ExecutiveOrderonAdvancingAmericanKidneyHealth_TheWhiteHouse.pdf . Accessed November 17, 2021. US Department of Health and Human Services: KidneyX. Available at https://www.kidneyx.org/ . Accessed November 17, 2021. Salani M, Roy S, Fissell WH 4th: Innovations in wearable and implantable artificial kidneys. Am J Kidney Dis 72: 745–751, 2018 https://doi.org/10.1053/j.ajkd.2018.06.005. (PMID: 10.1053/j.ajkd.2018.06.005) US Department of Health and Human Services: Federal Register Part 860—Medical Device Classification Procedures. Available at: https://www.govinfo.gov/content/pkg/CFR-2020-title21-vol8/pdf/CFR-2020-title21-vol8-part860.pdf . Accessed November 17, 2021. US Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health and Center for Biologics Evaluation and Research: Patient Preferences Information—Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decisions Summaries and Device Labeling. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-preference-information-voluntary-submission-review-premarket-approval-applications . Accessed November 17, 2021. US Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health and Center for Biologics Evaluation and Research: Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/factors-consider-when-making-benefit-risk-determinations-medical-device-premarket-approval-and-de . Accessed November 17, 2021. Benz HL, Saha A, Tarver ME: Integrating the voice of the patient into the medical device regulatory process using patient preference information. Value Health 23: 294–297, 2020 https://doi.org/10.1016/j.jval.2019.12.005. (PMID: 10.1016/j.jval.2019.12.005) Ho M, Saha A, McCleary KK, Levitan B, Christopher S, Zandlo K, Braithwaite RS, Hauber AB; Medical Device Innovation Consortium’s Patient Centered Benefit-Risk Steering Committee: A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health 19: 746–750, 2016 https://doi.org/10.1016/j.jval.2016.02.019. (PMID: 10.1016/j.jval.2016.02.019) Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, Flynn TN: Using qualitative methods for attribute development for discrete choice experiments: Issues and recommendations. Health Econ 21: 730–741, 2012 https://doi.org/10.1002/hec.1739. (PMID: 10.1002/hec.1739) Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, DiSantostefano R, Peay H: Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: Guidelines for authors and reviewers. Patient 13: 121–136, 2020 https://doi.org/10.1007/s40271-019-00401-x. (PMID: 10.1007/s40271-019-00401-x) Morgan DL, Ataie J, Carder P, Hoffman K: Introducing dyadic interviews as a method for collecting qualitative data. Qual Health Res 23: 1276–1284, 2013 https://doi.org/10.1177/1049732313501889. (PMID: 10.1177/1049732313501889) US Food and Drug Administration: Federal Food, Drug, and Cosmetic Act (FD&C Act). Available at: https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act . Accessed on April 4, 2022. Wolf MS, Smith SG, Pandit AU, Condon DM, Curtis LM, Griffith J, O’Conor R, Rush S, Bailey SC, Kaplan G, Haufle V, Martin D: Development and validation of the consumer health activation index. Med Decis Making 38: 334–343, 2018 https://doi.org/10.1177/0272989X17753392. (PMID: 10.1177/0272989X17753392) Hauber B, Coulter J: Using the threshold technique to elicit patient preferences: An introduction to the method and an overview of existing empirical applications. Appl Health Econ Health Policy 18: 31–46, 2020 https://doi.org/10.1007/s40258-019-00521-3. (PMID: 10.1007/s40258-019-00521-3) Kopec JA, Richardson CG, Llewellyn-Thomas H, Klinkhoff A, Carswell A, Chalmers A: Probabilistic threshold technique showed that patients’ preferences for specific trade-offs between pain relief and each side effect of treatment in osteoarthritis varied. J Clin Epidemiol 60: 929–938, 2007 https://doi.org/10.1016/j.jclinepi.2007.01.001. (PMID: 10.1016/j.jclinepi.2007.01.001) Llewellyn-Thomas HA: Threshold technique. In: The Encyclopedia of Medical Decision Making, edited by Kattan MW, Thousand Oaks, CA, Sage Publications, 2009, pp 1134–1137. Ericsson KA, Simon HA: Verbal reports as data. Psychol Rev 87: 215–251, 1980. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity—Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2—Assessing respondent understanding. Value Health 14: 978–988, 2011 https://doi.org/10.1016/j.jval.2011.06.013. (PMID: 10.1016/j.jval.2011.06.013) Birbili M: Translating from One Language to Another. Social Research Update, 2000. Available at: https://sru.soc.surrey.ac.uk/SRU31.html . Accessed April 22, 2022. Hsieh HF, Shannon SE: Three approaches to qualitative content analysis. Qual Health Res 15: 1277–1288, 2005 https://doi.org/10.1177/1049732305276687. (PMID: 10.1177/1049732305276687) Moser A, Korstjens I: Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract 24: 9–18, 2018 https://doi.org/10.1080/13814788.2017.1375091. (PMID: 10.1080/13814788.2017.1375091) Fotheringham J, Vilar E, Bansal T, Laboi P, Davenport A, Dunn L, Hole AR: Patient preferences for longer or more frequent in-center hemodialysis regimens: A multicenter discrete choice study [published online ahead of print October 23, 2021]. Am J Kidney Dis https://doi.org/10.1053/j.ajkd.2021.09.012. (PMID: 10.1053/j.ajkd.2021.09.012) Clark MD, Szczepura A, Gumber A, Howard K, Moro D, Morton RL: Measuring trade-offs in nephrology: A systematic review of discrete choice experiments and conjoint analysis studies. Nephrol Dial Transplant 33: 348–355, 2018 https://doi.org/10.1093/ndt/gfw436. (PMID: 10.1093/ndt/gfw436) Subramanian L, Zhao J, Zee J, Knaus M, Fagerlin A, Perry E, Swartz J, McCall M, Bryant N, Tentori F: Use of a decision aid for patients considering peritoneal dialysis and in-center hemodialysis: A randomized controlled trial. Am J Kidney Dis 74: 351–360, 2019 https://doi.org/10.1053/j.ajkd.2019.01.030. (PMID: 10.1053/j.ajkd.2019.01.030) Walker RC, Morton RL, Palmer SC, Marshall MR, Tong A, Howard K: A discrete choice study of patient preferences for dialysis modalities. Clin J Am Soc Nephrol 13: 100–108, 2018 https://doi.org/10.2215/CJN.06830617. (PMID: 10.2215/CJN.06830617) Medical Device Innovation Consortium (MCDIC): MDICx—A Case Study in How Patient Preference Information Contributes to Regulatory Decisions for Medical Devices. Available at: https://mdic.org/event/a-case-study-in-how-patient-preference-information-contributes-to-regulatory-decisions-for-medical-devices/ . Accessed November 17, 2021. Isakov L, Lo AW, Montazerhodjat V: Is the FDA too conservative or too aggressive? A Bayesian decision analysis of clinical trial design. J Econom 200: 117–136, 2019. Chaudhuri SE, Ho MP, Irony T, Sheldon M, Lo AW: Patient-centered clinical trials. Drug Discov Today 23: 395–401, 2018. Montazerhodjat V, Chaudhuri SE, Sargent DJ, Lo AW: Use of Bayesian decision analysis to minimize harm in patient-centered randomized clinical trials in oncology. JAMA Oncol 3: e170123, 2017. Medical Device Innovation Consortium: Patient Centered Benefit-Risk (PCBR) Framework. Available at: https://mdic.org/resource/patient-centered-benefit-risk-pcbr-framework/ . Accessed December 6, 2021. Medical Device Innovation Consortium: Patient Preference Study Design—Qualitative Steps: First Steps for Sponsors Initiating A Patient Preference Study. Available at: https://mdic.org/wp-content/uploads/2016/04/Patient-Preference-Study-Design-20171102.pdf . Accessed December 6, 2021.
معلومات مُعتمدة:	P30 DK114809 United States DK NIDDK NIH HHS
فهرسة مساهمة:	Keywords: ESRD; chronic dialysis; clinical trial; dialysis; end stage kidney disease; end stage renal disease; hemodialysis; innovation; kidney failure; patient preference; renal replacement therapy; wearable electronic devices
تواريخ الأحداث:	Date Created: 20220803 Date Completed: 20220804 Latest Revision: 20230109
رمز التحديث:	20230110
مُعرف محوري في PubMed:	PMC9337889
DOI:	10.34067/KID.0001862022
PMID:	35919522
قاعدة البيانات:	MEDLINE

Full Text Finder

الوصف
تدمد:	2641-7650
DOI:	10.34067/KID.0001862022